EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts
Open Access
- 7 March 2018
- Vol. 7 (1), 28
- https://doi.org/10.3390/pathogens7010028
Abstract
The contribution of Epstein-Barr virus (EBV) to the development of specific types of benign lymphoproliferations and malignant lymphomas has been extensively studied since the discovery of the virus over the last 50 years. The importance and better understanding of the EBV-associated lymphoproliferative disorders (LPD) of B, T or natural killer (NK) cell type has resulted in the recognition of new entities like EBV+ mucocutaneous ulcer or the addition of chronic active EBV (CAEBV) infection in the revised 2016 World Health Organization (WHO) lymphoma classification. In this article, we review the definitions, morphology, pathogenesis, and evolving concepts of the various EBV-associated disorders including EBV+ diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS), EBV+ mucocutaneous ulcer, DLBCL associated with chronic inflammation, fibrin-associated DLBCL, lymphomatoid granulomatosis, the EBV+ T and NK-cell LPD of childhood, aggressive NK leukaemia, extranodal NK/T-cell lymphoma, nasal type, and the new provisional entity of primary EBV+ nodal T- or NK-cell lymphoma. The current knowledge regarding the pathogenesis of B-cell lymphomas that can be EBV-associated including Burkitt lymphoma, plasmablastic lymphoma and classic Hodgkin lymphoma will be also explored.Keywords
This publication has 242 references indexed in Scilit:
- The genetic landscape of mutations in Burkitt lymphomaNature Genetics, 2012
- EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumorsJCI Insight, 2012
- IG/MYC Rearrangements are the Main Cytogenetic Alteration in Plasmablastic LymphomasThe American Journal of Surgical Pathology, 2010
- Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008Annals Of Oncology, 2009
- TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphomaThe Journal of Experimental Medicine, 2009
- AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH TranslocationsCell, 2008
- Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survivalBlood, 2007
- Galectin-1 mediated suppression of Epstein-Barr virus–specific T-cell immunity in classic Hodgkin lymphomaBlood, 2007
- Global mapping of c-Myc binding sites and target gene networks in human B cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- A sarcoma involving the jaws in african childrenBritish Journal of Surgery, 1958